SEC Form RW filed by Sunshine Biopharma Inc.
Sunshine Biopharma Inc.
333 Las Olas Way, CU4 Suite 433
Fort Lauderdale, FL 33301
August 12, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F. Street, N.E.
Washington, D.C. 20549
| Re: | Sunshine Biopharma Inc. | |
| Post-Effective Amendment No. 2 to Registration Statement on Form S-1 | ||
| Filed July 25, 2025 | ||
| File No. 333-276817 |
Dear Sir or Madam:
Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended, Sunshine Biopharma Inc. (the “Company”) hereby requests that the Securities and Exchange Commission consent to the withdrawal of the Company’s Post-Effective Amendment No. 2 to Registration Statement on Form S-1 (Registration No. 333-276817) (the “Post-Effective Amendment”). The Company is requesting withdrawal of the Post-Effective Amendment because the Company has filed a new registration statement for the securities it sought to have registered under the Post-Effective Amendment. No securities were sold pursuant to the Post-Effective Amendment.
Thank you for your assistance in this matter.
Very truly yours,
Sunshine Biopharma Inc.
By: /s/ Dr. Steve N. Slilaty
Name: Dr. Steve N. Slilaty
Title: Chief Executive Officer